CRIS - Company ID 0001108205
CURIS INC trades as CRIS. In its fiscal 2025 annual report the company posted revenue of $9.44M, down 13.4% from the prior year and net income of -$7.58M. This page tracks CURIS INC through 1,000 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Over the last 9 fiscal years CURIS INC's revenue grew from $7.53M to $9.44M, a compound annual growth rate of 2.6%. Net profit margin expanded from -802.6% to -80.3% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| PRE 14A | - | 2026-05-22 |
| Major company event | 8-K | 2026-05-22 |
| SCHEDULE 13G/A | - | 2026-05-15 |
| SCHEDULE 13G/A | - | 2026-05-14 |
| Quarterly report | 10-Q | 2026-05-13 |
| Major company event | 8-K | 2026-05-12 |
| Major company event | 8-K | 2026-05-01 |
| SCHEDULE 13G | - | 2026-04-24 |
The largest companies sharing CURIS INC's SEC industry classification (biological products, (no diagnostic substances)).
CURIS INC reported revenue of $9.44M for fiscal year 2025, a decrease of 13.4% year over year.
In its latest fiscal year CURIS INC reported a net loss of $7.58M.